$辉瑞(PFE)$ _老虎社区_美港股上老虎

$辉瑞(PFE)$ 智通财经APP获悉，美国制药巨头辉瑞公司(PFE.US)与本土初创企业杭州先为达生物科技股份有限公司达成协议，以获得后者一款减肥疗法在中国的独家商业化权益，此举旨在强化其在高增长减肥市场的布局。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":536265673708688,"tweetId":"536265673708688","gmtCreate":1771945214335,"gmtModify":1771947769612,"author":{"id":4136426194875310,"idStr":"4136426194875310","authorId":4136426194875310,"authorIdStr":"4136426194875310","name":"天蓝色的市场","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$&nbsp;</a> 智通财经APP获悉，美国制药巨头辉瑞公司(PFE.US)与本土初创企业杭州先为达生物科技股份有限公司达成协议，以获得后者一款减肥疗法在中国的独家商业化权益，此举旨在强化其在高增长减肥市场的布局。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$&nbsp;</a> 智通财经APP获悉，美国制药巨头辉瑞公司(PFE.US)与本土初创企业杭州先为达生物科技股份有限公司达成协议，以获得后者一款减肥疗法在中国的独家商业化权益，此举旨在强化其在高增长减肥市场的布局。</p></body></html>","text":"$辉瑞(PFE)$ 智通财经APP获悉，美国制药巨头辉瑞公司(PFE.US)与本土初创企业杭州先为达生物科技股份有限公司达成协议，以获得后者一款减肥疗法在中国的独家商业化权益，此举旨在强化其在高增长减肥市场的布局。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/536265673708688","repostId":0,"isVote":1,"tweetType":1,"viewCount":457,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":190,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}